Article Versions Notes

Heshin-Bekenstein M, Ziv A, Toplak N, Lazauskas S, Kadishevich D, Ben-Nun Yaari E, Miller-Barmak A, Butbul Aviel Y, Saiag E, Pel S, et al. Safety and Immunogenicity Following the Second and Third Doses of the BNT162b2 mRNA COVID-19 Vaccine in Adolescents with Juvenile-Onset Autoimmune Inflammatory Rheumatic Diseases: A Prospective Multicentre Study. Vaccines. 2023; 11(4):819. https://doi.org/10.3390/vaccines11040819

Heshin-Bekenstein, Merav, Amit Ziv, Natasa Toplak, Siman Lazauskas, Danielle Kadishevich, Efrat Ben-Nun Yaari, Adi Miller-Barmak, Yonatan Butbul Aviel, Esther Saiag, Sara Pel, and et al. 2023. "Safety and Immunogenicity Following the Second and Third Doses of the BNT162b2 mRNA COVID-19 Vaccine in Adolescents with Juvenile-Onset Autoimmune Inflammatory Rheumatic Diseases: A Prospective Multicentre Study" Vaccines 11, no. 4: 819. https://doi.org/10.3390/vaccines11040819